Skip to content

Effect of remazolam on plasma NFL concentration and postoperative delirium after non-cardiac major surgery in elderly patients with frailty: a prospective, randomized controlled clinical study

Effect of remazolam on plasma NFL concentration and postoperative delirium after non-cardiac major surgery in elderly patients with frailty: a prospective, randomized controlled clinical study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093862
Enrollment
Unknown
Registered
2024-12-12
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium (POD)

Interventions

Propofol general anesthesia group:Propofol general anesthesia
Rimazolen general anesthesia group:Rimazolen general anesthesia

Sponsors

The First Hospital Of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.This study included patients who underwent non cardiac surgery under general anesthesia with endotracheal intubation from January 2025 to December 2026, with a surgical duration of>60 minutes, aged >= 60 years, ASA I-III grade, and had stayed in the hospital for at least 72 hours after surgery. The study has been reviewed and approved by the hospital ethics committee, and all included patients have signed informed consent forms.

Exclusion criteria

Exclusion criteria: 1.The surgery is only performed under local anesthesia, regional anesthesia, or anesthesia monitoring; 2.Patients with previous mental illnesses, preoperative use of antipsychotic drugs, and alcohol withdrawal delirium; 3.Patients with second degree type 1 or above atrioventricular block, or acute myocardial infarction or stroke within 3 months; 4.Patients with severe liver and kidney diseases (Child pugh C grade liver, serum creatinine>442umol/L); 5.Patients with ASA grade IV or higher; 6.Patients who are allergic to any drugs related to the experiment.

Design outcomes

Primary

MeasureTime frame
Neurofilamentlightchain;Indicators of delirium;

Countries

China

Contacts

Public ContactZhou Qinghe

The First Hospital Of Jiaxing

jxxmxy@163.com+86 13732573379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026